BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, June 19, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

March 23, 2015

View Archived Issues

New assay using HEV-V-LP shows optimal performance in HEV seroprevalence diagnosis

Read More

Cell therapy for EBV-positive non-Hodgkin's lymphomas granted orphan status

Read More

Epothilone B shows potential for use after CNS injury

Read More

University of Nottingham licenses monoclonal antibody platforms from Open Monoclonal Technology

Read More

Patiromer controls hyperkalemia in HF patients receiving RAASi

Read More

New Fleming Fund aims to tackle drug-resistant infections

Read More

Anti-INSR MAb shows potential for the treatment of endogenous hyperinsulinemic hyperglycemia

Read More

AbbVie licenses anti-tau antibodies from C2N Diagnostics for Alzheimer's disease therapy

Read More

Lupin describes calcium sensing receptor modulators

Read More

Lilly and Hanmi to collaborate on development of BTK inhibitor HM-71224

Read More

Additional approvals for daclatasvir and asunaprevir in Japan

Read More

Trimel's testosterone nasal gel shows efficacy in hypogonadal men

Read More

JZoloft approved for post-traumatic stress disorder in Japan

Read More

FDA advisory committee recommends approval of BreoEllipta for asthma in adults

Read More

PTC Therapeutics and University of Pennsylvania form orphan disease research collaboration

Read More

Aurigene patents PD-1 signaling inhibitors

Read More

GlaxoSmithKline describe sGC activators

Read More

Piramal patents IGF-1 receptor inhibitors

Read More

MolMed and GSK enter strategic agreement in gene therapy

Read More

Kissei's doxapram approved in Japan for apnea of prematurity

Read More

Amgen AstellasBioPharma submits NDA for evolocumab in Japan

Read More

Silence Therapeutics reports results from phase Ib/IIa trial of ATU-027 in pancreatic cancer

Read More

NIH grants supports work at Scripps Research Institute on autophagy pathway for cancer

Read More

Eli Lilly and Innovent Biologics collaborate on cancer drug development in China

Read More

New formulation of Verona Pharma's RPL-554 well tolerated in healthy volunteers

Read More

ACS Denver: GSK second-generation HCV polymerase inhibitor shows promising results

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Brain with puzzle piece removed

    Gene replacement rescues autism-related phenotypes in mice

    BioWorld Science
    Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
  • Red blood cells, DNA

    For clonal hematopoiesis, epigenetics can be in driver’s seat

    BioWorld Science
    Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
  • Illustration of amyloid plaques in Alzheimer's disease

    Elixiron’s enrupatinib shows upbeat interim phase II AD results

    BioWorld
    Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing